Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations Publisher Pubmed



Hanaei S1, 2 ; Mohebi F3 ; Moradilakeh M4 ; Jabbari P1, 2 ; Mehta SK5 ; Kryvenko LS6 ; Luongo L7 ; Dupre L8 ; Rezaei N1, 2, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Research Associate, Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh, India
  6. 6. Kharkiv National Medical University, Kharkiv, Ukraine
  7. 7. Department of Experimental Medicine, University of Campania “L. Vanvitelli�, Naples, Italy
  8. 8. Ludwig Boltzmann Institute, Rare and Undiagnosed Diseases, Vienna, Austria
  9. 9. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Advances in Experimental Medicine and Biology Published:2021


Abstract

The coronavirus disease 2019 (COVID-19) outbreak started in late 2019 in Wuhan, Hubei Province of China, and quickly spread to the surrounding regions and neighboring countries. A novel coronavirus, the so-called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was found to be responsible for this outbreak potentially originating from pangolins. In China, the outbreak lasted for 1 month until it seemed to be controlled after affecting over 81,000 individuals and causing deaths in over 4200 patients. Subsequently, and after affecting over 118,000 individuals and causing over 4200 deaths, the condition was officially announced as a pandemic by the World Health Organization (WHO). In the meantime, the epidemic curve took a downtrend in China, the original epicenter of the pandemic, but started to rise in other countries with a steep slope. Among over 215 affected countries, the USA, European countries (Italy, Germany, Spain, France, the UK), Iran, and South Korea had the highest frequencies in the matters of infected patients and deaths. Importantly, different countries took different policies when encountered with an outbreak, especially in the matter of accuracy of the report and timing of the action. A part of the delays in reporting was expected, including the lag in the chain of reporting, the shortcomings of tests, missed patients, and inadequate testing facilities. However, there were also political and nontechnical reasons that caused the reporting to be inaccurate. Surveillance seems to be less of a reason for the observed in poor management, and it mostly originated from human decision-making failures and political issues. Besides, the culture of populations and their trust in their governments played an important role on how they reacted to the COVID-19 pandemic and acquired policies. Finally, the characteristics of the world today indicate the danger of probable upcoming outbreaks, and policymakers should utilize the existing opportunities, particularly the advancements in technology and media, to prevent or adequately manage them. © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
1. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
3. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
7. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
Experts (# of related papers)
Other Related Docs
9. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
12. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
14. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
16. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
20. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
27. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
28. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
33. Covid-19 Pandemic Is Not the Time of Trial and Error, American Journal of Emergency Medicine (2021)
34. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
35. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
38. Covid-19 and Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2020)
39. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
40. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
46. Role of Toll-Like Receptors in the Pathogenesis of Covid-19, Journal of Medical Virology (2021)
48. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
49. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)